13F-HR filed by DAFNA Capital Management LLC
DAFNA Capital Management LLC filed this 13F-HR for the quarter ended 2017-06-30, filed 2017-08-14, with 75 holding rows worth $140,138,000.
- Accession
- 0001389933-17-000023
- Filer
- CIK 1389933
- Filed
- 2017-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2017
A holdings report, 75 entries on the cover page, a total value of $140,138,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $140,138,000 with VALUE read as thousands by filing date, 13F file number 028-12327. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFischel Nathan028-12328
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LOXO ONCOLOGY INC | 548862101 | COM | 303,621 | $24,347,000 | thousands by filing date | |
| ATRICURE INC | 04963C209 | COM | 384,145 | $9,316,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 637,700 | $5,631,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 106,770 | $5,611,000 | thousands by filing date | |
| NXSTAGE MEDICAL INC | 67072V103 | COMMON STOCK | 216,119 | $5,418,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 82,000 | $4,155,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 591,128 | $3,287,000 | thousands by filing date | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 73,036 | $3,287,000 | thousands by filing date | |
| INSULET CORP COM | 45784P101 | Stock | 63,484 | $3,257,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 38,609 | $2,954,000 | thousands by filing date | |
| INSULET CORP | 45784PAD3 | NOTE 2.000% 6/1 | 2,250,000 | $2,746,000 | thousands by filing date | principal |
| ISHARES TR | 464287556 | ISHARES BIOTECH | 8,700 | $2,698,000 | thousands by filing date | |
| ALDER BIOPHARMACEUTICALS INC | 014339105 | COM | 221,013 | $2,531,000 | thousands by filing date | |
| BIOTELEMETRY INC | 090672106 | COM | 75,000 | $2,509,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 54,508 | $2,507,000 | thousands by filing date | |
| MINERVA NEUROSCIENCES INC COM NEW | 603380106 | Stock | 276,317 | $2,445,000 | thousands by filing date | |
| RADIUS HEALTH INC | 750469207 | COM NEW | 53,309 | $2,411,000 | thousands by filing date | |
| SUNESIS PHARMACEUTICALS INC | 867328700 | COM | 850,328 | $2,296,000 | thousands by filing date | |
| DERMIRA INC | 24983L104 | COM | 75,500 | $2,200,000 | thousands by filing date | |
| APPLIED GENETIC TECHNOL CORP | 03820J100 | COM | 421,000 | $2,147,000 | thousands by filing date | |
| SPECTRANETICS CORP | 84760C107 | COM | 55,896 | $2,146,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 119,200 | $2,087,000 | thousands by filing date | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 225,000 | $1,980,000 | thousands by filing date | |
| CELLECTIS ADS | 15117K103 | COM | 76,404 | $1,973,000 | thousands by filing date | |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 135,738 | $1,951,000 | thousands by filing date | |
| PROTALIX BIOTHERAPEUTICS INC | 74365AAB7 | NOTE 4.500% 9/1 | 2,500,000 | $1,936,000 | thousands by filing date | principal |
| ARDELYX INC | 039697107 | COM | 373,409 | $1,904,000 | thousands by filing date | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 204,808 | $1,835,000 | thousands by filing date | |
| DERMIRA INC | 24983LAA2 | NOTE 3.000% 5/1 | 1,500,000 | $1,665,000 | thousands by filing date | principal |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 355,667 | $1,650,000 | thousands by filing date | |
| ADVAXIS INC | 007624208 | COM NEW | 247,000 | $1,603,000 | thousands by filing date | |
| CIDARA THERAPEUTICS INC COM NEW | 171757107 | Stock | 208,458 | $1,563,000 | thousands by filing date | |
| NEOS THERAPEUTICS INC | 64052L106 | COM | 209,873 | $1,532,000 | thousands by filing date | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 349,592 | $1,346,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 203,907 | $1,262,000 | thousands by filing date | |
| Johnson & Johnson | 478160104 | COM | 9,400 | $1,244,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 266,500 | $1,223,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 443,478 | $1,211,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 377,695 | $1,190,000 | thousands by filing date | |
| NEURODERM LTD | M74231107 | ORD SHS | 37,938 | $1,134,000 | thousands by filing date | |
| ARQULE INC | 04269E107 | COM | 784,508 | $973,000 | thousands by filing date | |
| SYNERON MEDICAL LTD | M87245102 | ORD | 85,947 | $941,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 33,214 | $922,000 | thousands by filing date | |
| SCYNEXIS INC COM NEW | 811292101 | Common Stock | 506,900 | $907,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 40,000 | $848,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 8,000 | $840,000 | thousands by filing date | |
| BIOLINERX LTD-SPONS ADR | 09071M106 | SPON | 980,352 | $828,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 55,809 | $809,000 | thousands by filing date | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 1,372,862 | $796,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333XAD0 | DBCV 2.250% 6/1 | 573,000 | $767,000 | thousands by filing date | principal |
| EXACTECH INC | 30064E109 | COM | 23,136 | $689,000 | thousands by filing date | |
| COGENTIX MED INC COM | 19243A104 | Stock | 353,482 | $615,000 | thousands by filing date | |
| Tandem Diabetes Care, Inc. | 875372104 | COM | 724,286 | $579,000 | thousands by filing date | |
| Rocket Pharmaceuticals Inc | 45780V102 | SHS | 237,135 | $451,000 | thousands by filing date | |
| CASCADIAN THERAPEUTICS INC | 14740B606 | COM NEW | 117,310 | $436,000 | thousands by filing date | |
| GEMPHIRE THERAPEUTICS INC | 36870A108 | COM | 30,797 | $394,000 | thousands by filing date | |
| MASIMO CORP COM | 574795100 | Stock | 4,250 | $388,000 | thousands by filing date | |
| INOTEK PHARMACEUTICALS CORP | 45780VAB8 | NOTE 5.750% 8/0 | 600,000 | $369,000 | thousands by filing date | principal |
| SIERRA ONCOLOGY INC | 82640U107 | COM | 265,000 | $310,000 | thousands by filing date | |
| NATUS MEDICAL INC | 639050103 | COM | 7,900 | $295,000 | thousands by filing date | |
| CONATUS PHARMACEUTICALS INC | 20600T108 | COM | 50,000 | $288,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 35,977 | $284,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 15,550 | $262,000 | thousands by filing date | |
| DEXCOM INC | 252131AE7 | DBCV 0.750% 5/1 | 250,000 | $254,000 | thousands by filing date | principal |
| BELLICUM PHARMACEUTICALS INC | 079481107 | COM | 20,000 | $234,000 | thousands by filing date | |
| SPRING BK PHARMACEUTICALS IN | 849431101 | COM | 1,600 | $217,000 | thousands by filing date | |
| ObsEva SA | H5861P103 | COM | 25,000 | $214,000 | thousands by filing date | |
| EDGE THERAPEUTICS INC | 279870109 | COM | 19,400 | $199,000 | thousands by filing date | |
| AFFIMED N V | N01045108 | COM | 92,500 | $190,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 20,000 | $167,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 5,500 | $132,000 | thousands by filing date | |
| ADAMIS PHARMACEUTICALS CORP | 00547W208 | COM NEW | 24,401 | $127,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 19,067 | $110,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 20,000 | $88,000 | thousands by filing date | |
| GALENA BIOPHARMA INC COM NEW | 363256504 | Stock | 46,145 | $27,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001389933-17-000023 | this filing | 2017-08-14 | acceptance time not in the bulk data set |